학술논문

Bronchodilator Efficacy of High-Flow Nasal Cannula in COPD: Vibrating Mesh Nebulizer Versus Jet Nebulizer
Document Type
Clinical report
Source
Respiratory Care. February, 2024, Vol. 69 Issue 2, p157, 9 p.
Subject
Ontario
Thailand
Language
English
ISSN
0020-1324
Abstract
BACKGROUND: Jet nebulizers are commonly used for bronchodilator therapy in COPD. Highflow nasal cannula with vibrating mesh nebulizer (HFNC-VMN) is a recently developed system; however, few studies have compared the efficacy of bronchodilator administration via HFNC-VMN to jet nebulizer in stable COPD. This study aimed to compare the effect of salbutamol administered via HFNC-VMN versus jet nebulizer on airway and lung function in subjects with stable COPD. METHODS: This randomized non-inferiority crossover physiologic study enrolled subjects with stable COPD. Salbutamol was nebulized via HFNC-VMN or jet nebulizer in random order with a 4-h washout period between crossover sequences. Spirometry, lung volume, and impulse oscillometry were performed at baseline and after each intervention. The primary outcome was change in FE[V.sub.1] from baseline. Secondary outcomes included changes in other respiratory-related parameters and nebulization time compared between the 2 devices. RESULTS: Seventeen subjects were enrolled. HFNC-VMN and jet nebulizer both significantly improved FE[V.sub.1] from baseline (P = .005 and P =.002, respectively). The difference between respiratory resistance at 5 Hz and 20 Hz significantly decreased after HFNC-VMN compared to baseline (P = .02), while no significant change was observed after jet nebulizer (P = .056). Area of reactance and resonant frequency of reactance were both significantly decreased (P = .035 and P = .03, respectively), and respiratory reactance at 5 Hz significantly increased (P = .02) in the HFNC-VMN group compared to baseline indicating improved lung mechanics, with no significant changes with the jet nebulizer. HFNC-VMN had a shorter nebulization time (6 [5-9] min vs 20 [16-22] min, respectively, P < .001). CONCLUSIONS: Bronchodilator therapy via HFNC-VMN was not inferior to jet nebulizer for subjects with stable COPD and can significantly improve airway oscillometry mechanics and decrease nebulization time compared to jet nebulizer. Key words: aerosol therapy; COPD; high-flow nasal cannula; pulmonary function test; vibrating mesh nebulizer. [Respir Care 2024;69(2):157-165. [c] 2024 Daedalus Enterprises]
Introduction High-flow nasal cannula (HFNC) delivers heated and humidified air-oxygen mixtures through a large-bore nasal cannula with a flow up to 60 L/min and [F.sub.IO2] that can be titrated from [...]